Kyleena 19,5 mg Intrauterine devices.
PDF Leaflet Revision Date: 12 May 2023
Clinical Summary
Quick overview from the medicine insert
Indication
Contraception for up to 5 years in women 18 years and older.
Dosage (summary)
Inserted into the uterine cavity; can be replaced at any time in the cycle.
Special Populations
- Paediatric patients
- Geriatric patients
- Hepatic impairment
- Renal impairment
Pregnancy & Breastfeeding
Contraindicated in pregnancy; minimal transfer to breast milk, no adverse effects on infant.
Key Drug Interactions
- Phenytoin
- Carbamazepine
- Rifampicin
- St. John's wort
Contraindications
- Hypersensitivity to levonorgestrel
- Pregnancy
- Pelvic inflammatory disease
- Cervical neoplasm
- Uterine malignancy
- Acute liver disease
Common side effects
- Changes in menstrual bleeding
- Headache
- Abdominal pain
- Acne
- Device expulsion
Counselling Points
- Check for threads regularly
- Report heavy or irregular bleeding
- Monitor for signs of infection
Serious warnings
- Risk of ectopic pregnancy
- Pelvic infection
- Perforation risk during insertion
Important Disclaimer
The Kyleena 19,5 mg Intrauterine devices. professional information leaflet below is the property of Bayer and is provided on Medinsert exactly as issued, with no.. alterations or editorial changes. We make every effort to keep content current by updating documents as soon as new versions become available. Medinsert serves as a trusted access point for healthcare professionals, but does not replace official sources or clinical judgement. For more details, please read our full disclaimer. read more>>
Healthcare Professionals Only
This content is for registered healthcare professionals
Sign in or create a free account to read the full package insert.
Free for HPCSA-registered professionals. Powered by Medinsert.
